Powder Delivery TRIZ Cases

This case uses fatty-acid or fatty-alcohol levodopa derivatives and nano/microparticles to limit degradation and extend therapeutic action.

Ultra-low crosslinked particles combine fibrin targeting and metallic nanoparticles to support clotting, healing, and infection control.

This case combines PEG stabilization with pepducin targeting to limit aggregation, improve uptake, and enhance radiosensitization.

This case uses lecithinized superoxide dismutase to reduce ARDS edema, inflammation, and tissue injury.

A layered blister structure limits moisture, oxygen, and light exposure while supporting heat transfer during freezing and lyophilization.

Amorphous PARP inhibitor powders with cyclodextrin enable rapid dissolution, high bioavailability, and injectable emergency treatment.

Solid particles support probiotic biofilms that endure gut conditions, persist for five days, and release bacteria at intestinal pH.

This case forms poly(I:C) polyplex particles with cationic polymers to improve stability, uptake, and dosing consistency.

Cold-water-dispersible carriers and high-shear mixing limit aggregation while increasing surface area for hydrophobic compound absorption.

Hydrophilic and lipophilic nanosized cannabinoids address erratic absorption through quick outer-layer and sustained inner-core release.

Pre-mixed neostigmine and glycopyrrolate injectables use EDTA and sealed containers to limit degradation, contamination, and dosing errors.

This case shows how lipid bilayers and transmembrane peptides add membrane fluidity and secondary functionalization to bead platforms.

This case combines shorter perfluorocarbon chains with phospholipids to stabilize nanoemulsions while limiting metabolite buildup.

This case links virus- and mucin-binding moieties to anchor peptides in respiratory mucus and trap diverse viral pathogens.

APCs process phagocytosable HPV immunogen particles through MHC I and II pathways to expand responsive CD4+ and CD8+ T-cells.

Buffering and bulking agents support dry CNP conjugate storage with minimal premature release and stable therapeutic efficacy.

Specific monomer structures help cationic polymers complex mRNA, improve target-tissue expression, and limit formulation and delivery risks.

Continuous droplet dehydration forms circular biologic particles with low void space.

This case develops Formula (I) conjugates and compositions to inhibit tumors while limiting toxicity at tolerable doses.

VLP-based nanoparticles deliver non-PEGylated recombinant uricase with prolonged serum residence and lower immunogenicity.

Carrier constructs move biologics across gut epithelium while avoiding lysosomal degradation.

This case uses PACE-PEG and surface-conjugated targeting moieties to improve mRNA stability, uptake, and delivery while limiting toxicity.

This case links polyalkylene oxide to L-asparaginase, then lyophilizes it for storage stability, reduced clearance, and longer circulation.

This tadalafil suspension combines cyclodextrin, MCC-NaCMC, and xanthan gum to support stability and tablet-equivalent dissolution.

Histidine buffer, polysorbate, sucrose, and lyophilization support stable anti-CD38 formulations up to 65 mg/ml.

Porous liposomes use internal binders and neutral buoyancy to remove biotin, fluorescein, and bilirubin from biological assays.

Polymer nanoparticles decompose into metabolites inside cells, supporting adhesion, hemostasis, wound healing, and antibacterial activity.

This case uses allogeneic hypoimmune BioNVs with membrane CARs to target tumors while reducing immune interference and improving stability.

This case uses staged avian or rodent amniotic fluid extract to reduce fibrosis and improve cardiac function after infarction.

This case uses selectively binding chlorotoxin conjugates and fluorescent labels to visualize tumor margins during surgical resection.

This case uses oxidized carbon nanomaterials to convert H2S into polysulfides, addressing toxicity and narrow therapeutic index concerns.

Freeze-dried platelet derivatives restore hemostasis during antiplatelet therapy.

Sized neuroactive steroid particles combine rapid absorption with sustained plasma concentration, reducing reliance on 60-hour infusion.

This case uses two PEA particle-size fractions to reduce inflammation while supporting immune response without suppression.

Poorly soluble drugs are vaporized under vacuum and deposited as nanoparticles on excipient microparticles to improve dissolution.

Sterilized fecal-derived compositions preserve beneficial molecules without live organisms.

A 15% dietary fruit and vegetable powder supplement targets gut dysbiosis and inflammation to help prevent NAFLD and atherosclerosis.

Modified GvpC proteins tune gas vesicle collapse pressures for targeted, multiplexed ultrasound contrast imaging.

An A-D-A NIR-II probe uses white-light excitation and organic-coated nanoparticles for bright, uniform vascular imaging.

A high-flow aerosol generator delivers Houttuynia extract to reduce inflammatory cytokine expression in respiratory disease.

Nanoparticle-polysaccharide composite inks limit submucosal diffusion while supporting long-term gastrointestinal lesion imaging.

Binding-moiety PEG-lipids create targeted LNPs that improve nucleic acid delivery while limiting liver accumulation.

Controlled evaporation of BoNT/A and HSA solutions avoids freezing, reducing aggregates and supporting consistent quality during storage.

Controlled PVA particle sizing improves powder flowability for continuous extrusion dosing without additives.

This formulation combines binding agents and dispersants to maintain dispersibility while suppressing hydrate generation and crystal growth.

Adding inorganic carbonate to silica-absorbed propandiol mononitrate powder improves retention without overdosing or special packaging.

This process uses L-menthol resolution, staged separation, and cyclization to produce brivaracetam with impurities below 1%.

Degradable pH-sensitive micelles support repeat drug delivery without body accumulation.

Sulfonyl or phosphonyl linkers help keep platinum nanoparticle conjugates colloidally stable while enabling tumor-site drug release.

This case combines 10–30% Andrographis paniculata with phosphoryl ethanol amine to support antitumor activity while limiting toxicity.